Table 1.
Ferritin Shell | Extra Modification | Properties of Iron Core | Applications | References |
---|---|---|---|---|
apoFt | Superparamagnetic | MRI (T2) | [48] | |
W doped | Paramagnetic | MRI (T1) | [71] | |
HFt | Superparamagnetic | MRI (T2) | [63] | |
Peroxidase | Tumor diagnosis | [41,76] | ||
Superparamagnetic | Native tumor targeting | [41] | ||
Polymer mediated | Enhanced relaxivity | MRI (T2) | [77] | |
RGD linked | Superparamagnetic | Tumor targeting, MRI (T2) | [40] | |
α-MSH linked | Superparamagnetic | Selective targeting | [78] | |
Ultrafine Fe2O3 | Superparamagnetic | MRI (T1) | [47] | |
Co doped | Superparamagnetic, Enhanced relaxivity | Magnetize cells, MRI (T2) | [38] | |
Co doped | Peroxidase | Cancer diagnosis | [56] | |
Semigenetic | Superparamagnetic | THG, OA and MRI (T2) | [79] | |
125I conjugated | Superparamagnetic | SPECT imaging, MRI (T2) | [80] | |
Co doped | Enhanced magnetic Anisotropy | Hyperthermia | [46] | |
Cy5.5 labeled | High relaxivity | NIRF imaging, MRI (T2) | [81] | |
Re conjugated | Superparamagnetic | Radiotherapy, MRI (T2) | [82] | |
Self-organized | Magnetic scaffold | Control bioprocess | [83] | |
AfFt-AA | Enhanced relaxivity | MRI (T2) | [54] | |
PfFt | Assembly | Superparamagnetic | Control drug delivery | [37] |